1. Home
  2. BIO vs RKLB Comparison

BIO vs RKLB Comparison

Compare BIO & RKLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • RKLB
  • Stock Information
  • Founded
  • BIO 1952
  • RKLB 2006
  • Country
  • BIO United States
  • RKLB United States
  • Employees
  • BIO N/A
  • RKLB N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • RKLB Aerospace
  • Sector
  • BIO Industrials
  • RKLB Industrials
  • Exchange
  • BIO Nasdaq
  • RKLB Nasdaq
  • Market Cap
  • BIO 9.2B
  • RKLB 8.5B
  • IPO Year
  • BIO N/A
  • RKLB N/A
  • Fundamental
  • Price
  • BIO $245.57
  • RKLB $19.34
  • Analyst Decision
  • BIO Strong Buy
  • RKLB Buy
  • Analyst Count
  • BIO 4
  • RKLB 12
  • Target Price
  • BIO $415.25
  • RKLB $23.95
  • AVG Volume (30 Days)
  • BIO 397.4K
  • RKLB 14.6M
  • Earning Date
  • BIO 05-06-2025
  • RKLB 05-05-2025
  • Dividend Yield
  • BIO N/A
  • RKLB N/A
  • EPS Growth
  • BIO N/A
  • RKLB N/A
  • EPS
  • BIO N/A
  • RKLB N/A
  • Revenue
  • BIO $2,566,500,000.00
  • RKLB $436,214,000.00
  • Revenue This Year
  • BIO $1.11
  • RKLB $39.78
  • Revenue Next Year
  • BIO $4.55
  • RKLB $51.05
  • P/E Ratio
  • BIO N/A
  • RKLB N/A
  • Revenue Growth
  • BIO N/A
  • RKLB 78.34
  • 52 Week Low
  • BIO $235.84
  • RKLB $3.47
  • 52 Week High
  • BIO $387.99
  • RKLB $33.34
  • Technical
  • Relative Strength Index (RSI)
  • BIO 36.97
  • RKLB 47.18
  • Support Level
  • BIO $235.84
  • RKLB $17.11
  • Resistance Level
  • BIO $249.37
  • RKLB $19.79
  • Average True Range (ATR)
  • BIO 7.74
  • RKLB 1.14
  • MACD
  • BIO 1.47
  • RKLB 0.28
  • Stochastic Oscillator
  • BIO 39.59
  • RKLB 66.77

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About RKLB Rocket Lab USA Inc.

Rocket Lab USA Inc is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, rest of the world and earns key revenue from the United States.

Share on Social Networks: